Activity of Tedizolid and Comparator Agents Against Gram-positive Isolates Causing Skin and Skin Structure Infections in Pediatric Patients in United States Hospitals (2015-2019).
Cecilia Godoy CarvalhaesHelio Silva SaderPaul Richard RhombergMariana CastanheiraSean DeVriesRodrigo Elisandro MendesPublished in: The Pediatric infectious disease journal (2022)
Tedizolid was very active against a large collection of gram-positive pathogens causing skin and skin structure infection in pediatric patients, including MRSA isolates.